Eotaxin in Asthma

In Asthma, published studies report higher levels of Eotaxin than in healthy control subjects. The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The evidence summarised here comes from Whittle et al. 2019 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedOther

Summary

Direction in Asthma↑ Elevated — higher than in the comparison group
CategoryOther
Compared againsthealthy control subjects
SourceWhittle et al. 2019 — doi:10.1038/s41598-019-45257-1
Condition atlasAsthma Biomarker Atlas

Related Other markers in Asthma

Full list: Asthma Biomarker Atlas.

Frequently asked questions

Is Eotaxin high or low in Asthma?

Elevated. Studies summarised in the OSMF atlas report higher Eotaxin in Asthma than in healthy control subjects. Source: Whittle et al. 2019.

Which test measures Eotaxin?

The atlas record does not list a standardised clinical test code (LOINC) for Eotaxin, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal Eotaxin result diagnostic of Asthma?

No. No single biomarker is diagnostic of Asthma. Eotaxin findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Eotaxin in Asthma: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 8, 2026, from https://research.opensourcemed.info/biomarkers/asthma/eotaxin.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-10-08 · Page generated from asthma.json · Browse: Asthma atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.